CClinicalTrials.gg
Not yet recruitingNCT06496802Updated Jul 11, 2024

Prognostic Significance of Preoperative Nutritional Status on Postoperative Acute Kidney Injury

An observational study in Acute Kidney Injury and Pneumonectomy, sponsored by Wanmin Liao. Not yet recruiting. Open to participants aged 65 Years to 100 Years. Per ClinicalTrials.gov, last updated 2024-07-11.

Sponsored by Wanmin Liao · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,880
Ages
65 Years to 100 Years
Sex
All
01

Study summary

The incidence of postoperative acute kidney injury (AKI) is high in patients undergoing lung resection surgery, especially in the elderly. Early identification of high-risk postoperative AKI patients can help develop prevention and treatment management strategies.

Read the detailed description

The goal of this retrospective study is to investigate the predictive value of preoperative nutritional status, as measured by three scoring systems - the geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and controlling nutritional status (CONUT) score - on postoperative AKI in elderly patients under lung resection surgery.

02

Conditions studied

  • Acute Kidney Injury
  • Pneumonectomy

Keywords

  • Acute Kidney Injury
  • lung resection surgery
  • malnutrition
  • prediction model
03

In context

Acute Kidney Injury

1,594 studies on the registry are indexed under Acute Kidney Injury; 370 are open to participants now.

This study's planned enrollment of 1,880 is above the median of 151 across 772 observational studies indexed under Acute Kidney Injury.

Browse Acute Kidney Injury studies →

Lead sponsor

This is the only study on the registry with Wanmin Liao as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Older patients (aged ≥ 65 years) who underwent lung resection surgery under general anesthesia at our Hospital between January 2020 and June 2024 were included in our study. Lung resection surgery included pneumonectomy , bilobectomy , lobectomy, segmentectomy, wedge resection/bullectomy.

Inclusion criteria

  1. aged ≥ 65 years
  2. lung resection surgery including:pneumonectomy , bilobectomy , lobectomy, segmentectomy, wedge resection/bullectomy.

Exclusion criteria

Exclusion Criteria:

  1. patients with an American Society of Anesthesiologists (ASA) physical status V.
  2. those with end-stage renal disease (i.e. a glomerular filtration rate of 15 mL/min/1.73 m2 or receiving haemodialysis).
  3. those did not have sufficient data required for nutritional evaluation or AKI evaluation.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,880 participants (estimated)
Patient registry
No

Interventions

  • Otherno intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Postoperative acute kidney injury

    In accordance with the KDIGO creatinine criteria: a serum creatinine increases of 26.5 mmol/L within 48 hours or 1.5 times baseline within 7 days after surgery.

    Time frame: Within 7 days after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06496802
Lead sponsor
Wanmin Liao
Responsible party
Wanmin Liao (Professor, Tongji Hospital) — Sponsor-investigator
First posted
Jul 11, 2024
Start date
Jul 2024 (estimated)
Primary completion
Sep 15, 2024 (estimated)
Completion
Sep 15, 2024 (estimated)
Last update
Jul 11, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion